期刊文献+

LBW指数结合能谱CT在合理降低肝脏增强CT的CM剂量中的应用 被引量:3

Application of LBW index combined with energy spectrum CT in reducing the contrast agent dose of liver enhanced CT
下载PDF
导出
摘要 目的比较能谱CT扫描条件下去脂体质量(lean body weight, LBW)与全体质量(total body weight, TBW)作为指数计算肝脏增强CT对比剂药量的增强效果。方法连续纳入2018年11月至2019年1月在本院影像科行肝脏增强CT的218例患者,LBW组101例,TBW组117例。两组均采用能谱CT扫描,扫描和重建参数一致。使用的CM计算方法:LBW组的对比剂量为500 mgI/kg(LBW),TBW组的对比剂量为450 mgI/kg(TBW),注射速率均为2.8 mL/s。检查结束后将图像传输到GE AW4.7工作站,对50 keV单能量图像进行分析。比较两组患者的CM使用量、动脉期主动脉CT值(HU-aorta)、静脉期肝脏增强CT值(△-liver)、主动脉和肝脏增强达标率及变异度。结果与TBW组比较,LBW组CM剂量、HU-aorta和△-liver更低(P<0.05),LBW组和TBW组HU-aorta(91.09%vs. 90.60%)和△-liver(92.08%vs. 88.89%)的增强达标率无统计学差异(P>0.05)。LBW组HU-aorta和△-liver的变异度均明显低于TBW组,增强效果更一致。结论在能谱CT扫描前提下,使用LBW作为指数计算肝脏增强CT的药量,不仅可以减少造影剂用量,而且可以使患者的肝实质增强效果更加一致。 Objective To compare the enhancement effects of lean body weight(LBW) and total body weight(TBW)as indexes to calculate the contrast agent dosage under the condition of energy spectrum CT scanning. Methods A total of 218 patients who received liver enhancement CT from November 2018 to January 2019 were enrolled in this study. There were 101 patients in LBW group and 117 patients in TBW group. Both groups were scanned by energy spectrum CT, and the parameters of scanning and reconstruction were identical. The contrast agent dose was 500 mgI/kg(LBW) in LBW group and 450 mgI/kg(TBW) in TBW group, and the injection rate was 2. 8 mL/s. Images were transferred to a GE AW4. 7 workstation and the 50 keV monochromatic images were analyzed. We compared the dosage of contrast medium,CT value of aorta in arterial phase(HU-aorta),hepatic enhancement CT value in venous phase(-liver),the rate of reaching the enhancement standard and variability in the two groups. Results Compared with TBW group,LBW group had lower contrast agent dosage,HU-aorta and △-liver(P<0. 05),LBW and TBW group had no statistically different enhanced rate of HU-aorta as(91. 09% vs. 90. 60%) or △-liver(92. 08% vs. 88. 89%)(P>0. 05). The variation rate of HU-aorta and △-liver in LBW group was lower than that in TBW group. Using LBW as an index to calculate the dosage of liver enhanced CT also made the enhancement of liver parenchyma more consistent in different patients. Conclusion Even on the premise of energy spectrum CT scanning,using LBW-based contrast injection in liver enhanced CT can not only reduce contrast dose, but also make the enhancement in liver parenchyma more consistent among different patients.
作者 贾晓茜 王怡名 同维 屈媛 陈姣 韩春莹 田倩 朱书萌 郭建新 李淼 JIA Xiaoqian;WANG Yiming;TONG Wei;QU Yuan;CHEN Jiao;HAN Chunying;TIAN Qian;ZHU Shumeng;GUO Jianxin;LI Miao(Department of Radiology,The First Affiliated Hospital of Xi’an Jiaotong University,Xi’an 710061,China)
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2021年第6期880-884,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 陕西省重点研发计划项目-高校联合项目(No.2020GXLH-Y-026) 西安交通大学第一附属医院3D打印医学研究资助项目(No.XJTU1AF-3D-2018-003)。
关键词 去脂体质量 能谱CT 肝脏增强CT 对比剂 一致性 lean body weight energy spectrum CT liver enhanced CT contrast medium consistency
  • 相关文献

参考文献8

二级参考文献71

  • 1林盛才,廖锦元.多层螺旋CT在原发性肝癌经下肢静脉途径增强技术的研究进展[J].中国医学影像技术,2009,25(S1):218-220. 被引量:2
  • 2李铁一,李辉,肖国文,王铁根.胸部螺旋CT技术参数的最佳选择及应用[J].中华放射学杂志,1995,29(12):829-833. 被引量:15
  • 3李健,杜绪仓,吴晓红,王养民,于天智,方西玲,蔚兴堂.CT技术全面质量管理的探讨[J].中华放射学杂志,1995,29(9):640-642. 被引量:5
  • 4于香.《消费者权益保护法》对医患关系的适用——以病人权利为中心的分析[J].中国卫生法制,2007,15(4):34-36. 被引量:5
  • 5Waybill MM, Waybill PN. Contrast media-induced nephrotoxici- ty: Identification of patients at risk and algorithms for preven- tion. J Vasc Interv Radiol, 2001,12(1) :3-9.
  • 6Arana E, Marti-Bonmati L, Tobarra E, et al. Cost reduction in abdominal CT by weight-adjusted dose. Eur .l Radiol, 2009, 70 (3) :507-511.
  • 7Ichikawa T, Erturk SM, Araki T. Multiphasic contrast-enhancedmultideteetor-row CT of liver: Contrast-enhancement theory and practical scan protocol with a combination of fixed injection dura- tion and patients" body-weight-tailored dose of contrast material. Eur J Radiol, 2006,58(2) :165-176.
  • 8Awai K, Hiraishi K, Hori S. Effect of contrast material injection duration and rate on aortic peak time and peak enhancement at dy- namic CT involving injection protocol with dose tailored to patient weight. Radiology, 2004,230(1) : 142-150.
  • 9Marenzi G, Lauri G, Assanelli E, et al. Contrast-induced ne- phropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol, 2004, 44 (9) : 1780- 1785.
  • 10Davidson C, Stacul F, Mccullough PA, et al. Contrast medium use. Am J Cardiol, 2006,98(6A) :42K-58K.

共引文献124

同被引文献17

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部